Nasdaq:US$13.41 (-0.23) | HKEX:HK$21.15 (+0.00) | AIM:£2.18 (-0.03)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 其他业务 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture